Abbott Laboratories (ABT)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:35AM EDT. Market open.
| Previous close | 106.86 |
| Open | 106.51 |
| Bid | 107.32 x 800 |
| Ask | 107.36 x 800 |
| Day's range | 106.42 - 107.47 |
| 52-week range | 89.67 - 121.64 |
| Volume | |
| Avg. volume | 5,831,382 |
| Market cap | 186.22B |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | 33.43 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.20 (2.06%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Zacks
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- Simply Wall St.
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation
Key Insights Abbott Laboratories to hold its Annual General Meeting on 26th of April Total pay for CEO Robert Ford...
- Insider Monkey
Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. The US stock market started 2024 optimistically. In the first quarter, the fund returned 8.29% (gross) and 8.09% (net) compared to 11.41% for the Russell 1000 Growth Index and […]
© 2024 Yahoo. All rights reserved.